The HemoCue® Glucose 201 DM System is used in screening, monitoring and as an aid in the diagnosis of diabetes mellitus. With its unique microcuvette technology, the system provides the highest accuracy at the point of care while minimizing the risk of spreading infection. Plus, you have the added controls and productivity made possible with advanced data management.
Key benefits
With instant data connection, customizable prompts and more, you gain tighter control of authorized use and higher efficiency in everything from patient management to billing. The integrated data management functionality improves patient safety by ensuring tests are performed by the right person for the right patient. Plus, you have access to lockout functions.
02 Automatic transfer of results
03 Reduced manual entry errors
04 Individually wrapped microcuvettes to avoid contamination
05 Built-in quality control self-test
06 Customizable automatic prompts for patient ID, operator ID etc.
System specifications
Principle
Modified glucose degydrogenase in which the total amount of glucose is measured at the end point photometrically
Calibration
Factory calibrated and traceable to the ID GC-MS method; needs no further calibration and no coding
Measurement range
Plasma equivalent values: 0.61-24.6 mmol/L (11-444 mg/dL)
Whole blood values: 0.55-22.2 mmol/L (10-400 mg/dL)
Measuring time
Including data entry, within 1 minute for normal glucose levels
Storage temperature
Analyzer: 0-50°C (32-122°F)
Microcuvettes: below 8°C (46°F), room temperature for up to 3 days; one-month open vial stability
Operating temperature
18-30°C (64-86°F)